A detailed history of Caitlin John, LLC transactions in Pfizer Inc stock. As of the latest transaction made, Caitlin John, LLC holds 3,788 shares of PFE stock, worth $101,745. This represents 0.07% of its overall portfolio holdings.

Number of Shares
3,788
Previous 21,241 82.17%
Holding current value
$101,745
Previous $568 Million 82.29%
% of portfolio
0.07%
Previous 0.35%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Jan 27, 2025

SELL
$24.8 - $30.19 $432,834 - $526,906
-17,453 Reduced 82.17%
3,788 $101 Million
Q3 2024

Nov 14, 2024

BUY
$27.7 - $31.39 $504,195 - $571,360
18,202 Added 598.95%
21,241 $568 Million
Q2 2024

Jan 27, 2025

BUY
$25.26 - $29.6 $460,110 - $539,164
18,215 Added 480.86%
22,003 $616 Million
Q1 2024

Jan 27, 2025

BUY
$25.89 - $29.73 $25,941 - $29,789
1,002 Added 26.45%
4,790 $133 Million
Q4 2023

Feb 14, 2024

BUY
$26.13 - $33.94 $79,409 - $103,143
3,039 New
3,039 $87.5 Million

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $151B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Caitlin John, LLC Portfolio

Follow Caitlin John, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Caitlin John, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Caitlin John, LLC with notifications on news.